Diaceutics EU IVDR Implementation Woes Could Severely Limit Cancer Companion Test, Precision Therapy Access Premium The EC has stuck with its timeline to implement the new regulations in eight months, raising concerns for cancer patients' ability to receive biomarker testing and treatments. LGC SeraCare Joins Diaceutics DXRX Network for Precision Medicine Diagnostics The partnership will introduce additional types of test reference materials to users of the platform, including the Seraseq FFPE Tumor Fusion RNA Reference Material v4. Diaceutics, Alva10 Gathering Evidence Base for Improving PD-L1 Test Reimbursement Premium The companies will work with labs to improve payors' understanding of the costs of performing PD-L1 testing and the value it provides to patient care. Diaceutics Developing New Platform to Improve Access to Precision Medicine Premium The DXRX marketplace, planned for launch in the fourth quarter of 2020, will provide a way for pharmaceutical companies, diagnostic firms, and laboratories to collaborate. Amid COVID-19, Lower Cancer Diagnosis Rates Mean Fewer Patients Getting Molecular Tests, Treatment Premium Data amassed by analytics firm Diaceutics suggests fewer patients are coming into healthcare facilities and missing the chance for diagnosis, molecular testing, and treatment. Apr 19, 2020 Despite FDA Guidance, CDx Providers Still Have Challenges in Seeking 'Therapeutic Group' Indication Premium Oct 22, 2019 Report Says Many Precision Drugs Will Launch in Coming Years But Unclear if They Will Reach Patients Premium Sep 23, 2019 Global Survey Reveals Suboptimal Molecular Testing Access in Lung Cancer Despite Broad Guidelines Premium Feb 4, 2019 Delayed Testing, Limited Patient Understanding May Hinder Precision Oncology Access, Survey Suggests Premium May 22, 2017 Cancer Patients Missing Personalized Therapy Due to Quality Issues for Genetic Tests Apr 24, 2017 Diaceutics Inks Deal for BioReference Labs Dx Data Feb 28, 2017 Q&A: Labceutics' Jordan Clark on Industry, FDA Gap on Rx/Dx Codevelopment Principles Premium Jan 9, 2017 In 2016, Personalized Medicine Saw More CDx Deals, Flexible FDA, No LDT Guidance Premium Feb 1, 2016 New Complementary Dx Category Provides Regulatory Flexibility, but Poses Real World Challenges Premium May 28, 2015 ARUP, Labceutics Partner to Provide Lab Services to Personalized Drug Developers Nov 12, 2014 Report Finds More Personalized Rx on the Market, but Field Lacks 'Integrator' Premium Mar 19, 2014 Amid Regulatory and Reimbursement Difficulties, Some Encouraging Advancements for Personalized Rx Premium Mar 12, 2014 Pharma Slowly Adapting to Complexities and Challenges of Developing Personalized Medicine Premium Dec 18, 2013 People in the News: Peter Kim, Julie Goonewardene, Walter Capone Premium Dec 11, 2013 MDx/CDx Focus: Diaceutics, CAHG Launch Bioceutics; LabCorp Submits IDE for Gencaro CDx Premium Mar 13, 2013 Labceutics, Asuragen Conducting BCR-ABL Quality Assurance Study Among European Labs Premium Dec 12, 2012 With Decode Purchase, Amgen Gains Genetics Expertise, Consumers Lose DTC Testing Option Premium Nov 2, 2012 Dx Assays Launches Fee-for-Service CDx Development Initiative Giving Pharma More Control Premium Jun 27, 2012 MDx/CDx Focus: Cellceutix Planning Phase I Study for Kevetrin; Labceutics Launches EU Lab Network Premium Mar 14, 2012 Survey Finds Pharma Needs to Strategically Engage EU Labs when Launching Personalized Rx Products Premium Load More Breaking News Delic Partners With GT Research for Genetic Analysis of Cannabis, Psychedelic Mushrooms Indivumed, Biognosys Expand Partnership to Offer Immunopeptidomics Insights Multiomic Study Identifies Drivers of Severe COVID-19 in Patients Under 50 Without Comorbidities Yourgene H1 2022 Revenues More Than Double Gencove Raises $10M in Series A Financing Blueprint Genetics, BioMarin to Offer Genetic Testing for Skeletal Dysplasia in Europe, Middle East The Scan Should've Been Spotted Sooner Scientists tell the Guardian that SARS-CoV-2 testing issues at a UK lab should have been noticed earlier. For Martian Fuel Researchers have outlined a plan to produce rocket fuel on Mars that uses a combination of sunlight, carbon dioxide, frozen water, cyanobacteria, and engineered E. coli, according to Gizmodo. To Boost Rapid Testing The Washington Post writes that new US programs aim to boost the availability of rapid at-home SARS-CoV-2 tests. PNAS Papers on Strawberry Evolution, Cell Cycle Regulators, False-Positive Triplex Gene Editing In PNAS this week: strawberry pan-genome, cell cycle-related roles for MDM2 and MDMX, and more.